Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America.
暂无分享,去创建一个
Daniel M. Hartung | P. Tappenden | B. Sharrack | J. Snowden | Xiaoqiang Han | R. Burt | D. Hartung | K. Quigley | I. Arnautovic | Kathleen Quigley